Skip to main content
You have permission to edit this article.
Edit

Prime Healthcare Services, Inc. Schedules 2022 1st Quarter Earnings Conference Call

Prime Healthcare Services, Inc. announced its 1st Quarter and 2022 financial results on May 13, 2022. The Company will host a conference call on May 19, 2022, at 4:00 p.m. (ET) to discuss the 1st-quarter results.

To access the conference call, please dial (323) 794-2093 (U.S.) or (800) 289-0571 (toll-free) and reference Conference ID number 7556111. The number should be dialed five-ten minutes prior to the start of the conference call.

For those who are unable to listen to the conference call, there will be a replay available through Friday June 3, 2022, which can be accessed by dialing (719) 457-0820 (U.S.) or (888) 203-1112 (toll-free), passcode 7556111.

About Prime Healthcare: Prime Healthcare is an award-winning health system operating 45 hospitals and more than 300 outpatient locations in 14 states, providing over 2.6 million patient visits annually. It is one of the nation’s leading health systems with nearly 50,000 employees and physicians dedicated to providing the highest quality healthcare. Fourteen of the Prime Healthcare hospitals are members of the Prime Healthcare Foundation, a 501(c)(3) not-for-profit public charity. Based in Ontario, California, Prime Healthcare is nationally recognized for award-winning quality care and has been named a Top 10 and Top 15 Health System by IBM Watson Health. Its hospitals have been named among the nation’s “100 Top Hospitals” 58 times and have received more Patient Safety Excellence Awards from Healthgrades than any other health system in the past six years. To learn more, please visit www.primehealthcare.com.

Find us on:

LinkedIn: linkedin.com/company/prime-healthcare / Twitter: twitter.com/_PrimeHealth

Facebook: facebook.com/primehealthcare / Instagram: instagram.com/prime_healthcare/

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.